HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Matthias Loebe George P. Noon Roland Hetzer Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koster, A. Articles by Hetzer, R. Search for Related Content PubMed PubMed Citation Articles by Koster, A. Articles by Hetzer, R.

Ann Thorac Surg 2000;70:533-537
© 2000 The Society of Thoracic Surgeons

---

Original articles: cardiovascular

Alterations in coagulation after implantation of a pulsatile Novacor LVAD and the axial flow micromed DeBakey LVAD

^a Department of Anesthesia, Deutsches Herzzentrum Berlin, Berlin, Germany
^b Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Berlin, Germany

Address reprint requests to Dr Koster, Deutsches Herzzentrum Berlin, Augustenburgerplatz 1, D-13353 Berlin, Germany
e-mail: koster{at}dhzb.de

Background. The MicroMed DeBakey left ventricular assist device (LVAD) is a chamber and valveless axial flow blood pump. We investigated parameters of the coagulation system in patients after implantation of the axial flow LVAD and patients following implantation of a pulsatile Novacor LVAD.

Methods. Six consecutive patients of both groups were investigated over a period of 6 weeks after implantation. ß-Thromboglobulin, platelet factor 4, factor XIIa, thrombin/antithrombin complexes, plasmin/₂-antiplasmin complexes, and D-Dimer levels were measured.

Results. With the exception of the plasmin/₂-antiplasmin levels in the Novacor group, all parameters were elevated in both groups. The levels of ß-thromboglobulin, platelet factor 4, factor XIIa, and plasmin/₂-antiplasmin were significantly increased in the axial flow LVAD group.

Conclusions. The axial flow LVAD strongly influences the systems of contact activation and fibrinolysis. The elevation of platelet proteins appears to follow platelet damage. Although no thromboembolic events were observed in both groups, elevation of thrombin/antithrombin complexes provides convincing evidence of an increased activation of the coagulation system and the concomitant risk for the development of thromboembolism.

This article has been cited by other articles:

				D. Esmore, P. Spratt, R. Larbalestier, S. Tsui, A. Fiane, P. Ruygrok, D. Meyers, and J. Woodard VentrAssistTM left ventricular assist device: clinical trial results and Clinical Development Plan update Eur. J. Cardiothorac. Surg., November 1, 2007; 32(5): 735 - 744. [Abstract] [Full Text] [PDF]

				A. Koster, S. Huebler, E. Potapov, O. Meyer, M. Jurmann, Y. Weng, M. Pasic, T. Drews, H. Kuppe, M. Loebe, et al. Impact of Heparin-Induced Thrombocytopenia on Outcome in Patients with Ventricular Assist Device Support: Single-Institution Experience in 358 Consecutive Patients Ann. Thorac. Surg., January 1, 2007; 83(1): 72 - 76. [Abstract] [Full Text] [PDF]

				Y. Ootaki, K. Kamohara, M. Akiyama, F. Zahr, M. W. Kopcak Jr., R. Dessoffy, and K. Fukamachi Phasic coronary blood flow pattern during a continuous flow left ventricular assist support Eur. J. Cardiothorac. Surg., November 1, 2005; 28(5): 711 - 716. [Abstract] [Full Text] [PDF]

				M. J. Wilhelm, D. Hammel, C. Schmid, A. Rhode, T. Kaan, M. Rothenburger, J. Stypmann, M. Schafers, C. Schmidt, H. A. Baba, et al. Long-term support of 9 patients with the DeBakey VAD for more than 200 days J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1122 - 1129. [Abstract] [Full Text] [PDF]

				R. Houel, E. Mazoyer, B. Boval, M. Kirsch, E. Vermes, L. Drouet, and D. Y. Loisance Platelet activation and aggregation profile in prolonged external ventricular support J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 197 - 202. [Abstract] [Full Text] [PDF]

				R. Hetzer, Y. Weng, E. V. Potapov, M. Pasic, T. Drews, M. Jurmann, E. Hennig, and J. Muller First experiences with a novel magnetically suspended axial flow left ventricular assist device Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 964 - 970. [Abstract] [Full Text] [PDF]

				E. V. Potapov, S. Ignatenko, B. A. Nasseri, M. Loebe, C. Harke, M. Bettmann, A. Doller, V. Regitz-Zagrosek, and R. Hetzer Clinical significance of PlA polymorphism of platelet GP IIb/IIIa receptors during long-term VAD support Ann. Thorac. Surg., March 1, 2004; 77(3): 869 - 874. [Abstract] [Full Text] [PDF]

				R. Hetzer, E. V. Potapov, Y. Weng, H. Sinawski, F. Knollmann, T. Komoda, E. Hennig, and M. Pasic Implantation of MicroMed DeBakey VAD through left thoracotomy after previous median sternotomy operations Ann. Thorac. Surg., January 1, 2004; 77(1): 347 - 350. [Abstract] [Full Text] [PDF]

				E. V. Potapov, Y. Weng, H. Hausmann, M. Kopitz, M. Pasic, and R. Hetzer New approach in treatment of acute cardiogenic shock requiring mechanical circulatory support Ann. Thorac. Surg., December 1, 2003; 76(6): 2112 - 2114. [Abstract] [Full Text] [PDF]

				E. Vitali, M. Lanfranconi, E. Ribera, G. Bruschi, T. Colombo, M. Frigerio, and C. Russo Successful experience in bridging patients to heart transplantation with the MicroMed Debakey ventricular assist device Ann. Thorac. Surg., April 1, 2003; 75(4): 1200 - 1204. [Abstract] [Full Text] [PDF]

				B. A. J. M. de Mol Mechanical Support in Acute Perioperative Heart Failure: Are Assist Devices Smart Enough to Heal the Heart? Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 105 - 109. [PDF]